More than six years following the start of the Covid pandemic, millions of people continue to experience symptoms associated with long Covid. Researchers at University College London and University College London Hospitals conducted a clinical trial examining potential treatments for the condition. The study evaluated over-the-counter antihistamines combined with colchicine, a prescription anti-inflammatory medication. Results indicated that this treatment combination produced a small reduction in fatigue among long Covid patients, though investigators stressed that the intervention does not represent a cure for the condition.
Professor Danny Altmann, an immunologist at Imperial College London, discussed the implications of this research alongside broader challenges in understanding long Covid. He also highlighted several upcoming studies that may advance scientific knowledge of the condition and improve clinical approaches to managing its symptoms.
In related healthcare developments, approximately one in 335 people in the United Kingdom are living with a stoma. However, data from Colostomy UK indicates that more than 60 per cent of individuals with a stoma report that inadequate toilet facilities negatively affect their daily activities. Following a campaign originating in Bristol, the retail chain B&Q modified disabled toilet facilities across its stores to accommodate the needs of stoma patients. The changes were demonstrated in collaboration with television personality Mollie Pearce, who has lived with a stoma since age 18, and colorectal surgeon Caroline Burt from Bristol Foundation Trust.
Separately, claims have circulated on social media suggesting that ice cream consumption may reduce the risk of developing type 2 diabetes. Nutritional scientist Dr Sarah Berry from King’s College London addressed this assertion, examining what has been termed the ‘ice cream paradox’ and providing evidence-based analysis of the claim.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI